Rachel Thompson
Papers
1
Total Citations
6
H-Index
1
About
Dr. Rachel Thompson is a leading biotechnologist specializing in mRNA vaccine analytics and quality control. Her primary research focuses on the detection and quantification of process-related impurities in mRNA therapeutics, particularly double-stranded RNA (dsRNA) byproducts generated during in vitro transcription. Dr. Thompson’s major contribution is the development and validation of an automated sandwich ELISA platform that enables high-throughput, sensitive quantitation of residual dsRNA in mRNA vaccine formulations. This work directly addresses a critical safety and potency concern in the rapidly advancing field of mRNA-based medicine. Her landmark 2024 paper on this methodology has already garnered 6 citations, reflecting its immediate relevance to both academic researchers and industrial vaccine manufacturers. By providing a robust, scalable solution for impurity monitoring, Dr. Thompson’s innovations help ensure the consistency and safety of next-generation vaccines, supporting global efforts to combat infectious diseases. Her achievements position her as a key figure in bridging analytical chemistry with cutting-edge vaccine technology.
Research Focus
Key Achievements
Top Papers
- 1